"It is unknown at this time if there will be additional litigation surrounding this specific product," Rosalie Louis of Lynch ...
Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...
The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback